跳至主要内容
临床试验/NCT01303250
NCT01303250终止4 期

Balanced 6 % HES 130/0.4 vs. Balanced Crystalloid-based Infusion in Patients Undergoing Colorectal Surgery

University Hospital Muenster1 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2011年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
终止
发起方
入组人数
31
试验地点
1
主要终点
Total amount of administered fluids

研究概览

简要总结

The primary purpose of this study is to determine the effect of a balanced 6%hydroxyethyl starch 130/0.4 vs. a balanced crystalloid in colorectal surgery. The intraoperative fluid management will be given to optimize the stroke volume variation <= 12%.

The investigators hypothesize that patients in the intervention group will need less fluid administration be optimal hemodynamic stabilized.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients undergoing elective colorectal surgery
  • minimum age 18 years
  • informed consent

排除标准

  • patients with severe cardiomyopathy or severe heart failure
  • history of coagulation disorders
  • intracranial hemorrhage
  • patients with severe cardiovascular or respiratory disorders
  • renal insufficiency
  • severe liver diseases

研究组 & 干预措施

Group 1

Experimental

A balanced hydroxyethyl starch 130/0.4 will be used

干预措施: balanced 6% hydroxyethylstarch 130/0.4 (Drug)

Group 2

Active Comparator

A balanced crystalloid will be used

干预措施: balanced crystalloid (Drug)

结局指标

主要结局

Total amount of administered fluids

时间窗: intraoperatively

Total amount of administered fluids intraoperatively that is necessary to keep patients optimal hemodynamic stabilized

次要结局

  • Incidence of surgery related complications(day 28 and 90 postoperatively)

研究者

发起方
University Hospital Muenster
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Perioperative Colloid vs Crystalloid in Patients... | 临床试验